Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

12.14
Delayed Data
As of Feb 27
 -0.35 / -2.80%
Today’s Change
2.45
Today|||52-Week Range
16.87
-0.90%
Year-to-Date

Today’s Trading

Previous close12.49
Today’s open12.50
Day’s range12.02 - 12.55
Volume5,401,415
Average volume (3 months)6,957,548
Market cap$1.4B
Dividend yield--
Data as of 3:59pm ET, 02/27/2015

Growth & Valuation

Earnings growth (last year)+1.56%
Earnings growth (this year)-5.09%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book7.68

Competitors

 Today’s
change
Today’s
% change
ACORAcorda Therapeutics ...-1.72-4.84%
ZIOPZIOPHARM Oncology In...-0.52-4.41%
USNAUSANA Health Science...-4.97-4.73%
TTPHTetraphase Pharmaceu...-2.74-6.49%
Data as of 4:02pm ET, 02/27/2015

Financials

Next reporting dateMarch 4, 2015
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$58.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account